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Abstract
Background: Elbow dislocations can be classified as simple or complex. Simple dislocations are characterized by
the absence of fractures, while complex dislocations are associated with fractures of the radial head, olecranon, or
coronoid process. The majority of patients with these complex dislocations are treated with open reduction and
internal fixation (ORIF), or arthroplasty in case of a non-reconstructable radial head fracture. If the elbow joint
remains unstable after fracture fixation, a hinged elbow fixator can be applied. The fixator provides stability to the
elbow joint, and allows for early mobilization. The latter may be important for preventing stiffness of the joint. The
aim of this study is to determine the effect of early mobilization with a hinged external elbow fixator on clinical
outcome in patients with complex elbow dislocations with residual instability following fracture fixation.
Methods/Design: The design of the study will be a multicenter prospective cohort study of 30 patients who have
sustained a complex elbow dislocation and are treated with a hinged elbow fixator following fracture fixation
because of residual instability. Early active motion exercises within the limits of pain will be started immediately after
surgery under supervision of a physical therapist. Outcome will be evaluated at regular intervals over the subsequent
12 months. The primary outcome is the Quick Disabilities of the Arm, Shoulder, and Hand score. The secondary
outcome measures are the Mayo Elbow Performance Index, Oxford Elbow Score, pain level at both sides, range of
motion of the elbow joint at both sides, radiographic healing of the fractures and formation of periarticular
ossifications, rate of secondary interventions and complications, and health-related quality of life (Short-Form 36).
Discussion: The outcome of this study will yield quantitative data on the functional outcome in patients with a
complex elbow dislocation and who are treated with ORIF and additional stabilization with a hinged elbow fixator.
Trial Registration: The trial is registered at the Netherlands Trial Register (NTR1996).
Background
The elbow joint is the second most commonly dislo-
cated joint in adults. The annual incidence of elbow dis-
locations in children and adults is 6.1 per 100,000 [1].
Elbow dislocations are classified as being simple or com-
plex [2]. Simple dislocations are dislocations without
fractures. Complex dislocations are associated with frac-
tures of the radial head, olecranon, or coronoid process.
In patients with an elbow dislocation the incidence of
radial head fractures is 36%, whereas coronoid process
fractures occur in 13%, and olecranon fractures in four
percent of patients [1].
The radial head and coronoid process are considered
to be important bony stabilizers of the elbow. The fun-
damental goal in the management of complex elbow
dislocations is the restoration of the osseous-articular
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any medium, provided the original work is properly cited.restraints. Therefore, the majority of these complex dis-
locations is treated with open reduction and internal
fixation (ORIF) [3] or primary arthroplasty in case of a
non-reconstructable radial head fracture.
Assessment of stability of the joint following ORIF of
a complex elbow dislocation is essential. Signs of
instability are redislocation, a positive pivot shift test
and positive valgus and varus stress testing. At present
instability following ORIF or arthroplasty is usually trea-
ted with primary ligament repair and/or a period of
plaster immobilization.
A period of plaster immobilization may result in a lim-
ited range of motion and a stiff elbow with subsequent
disability. A hinged external elbow fixator, on the other
hand, may provide enough stability to start early mobili-
z a t i o na f t e rO R I Fo ra r t h r o p l a s t ya n dm a yp r e v e n tr e s i -
dual instability and stiffness [4,5]. No randomized
controlled trials comparing hinged external fixation and
plaster immobilization are available. This may be due to
the low incidence of patients with a complex elbow dislo-
cation with remaining instability after ORIF or arthro-
plasty. Until now only small observational studies of
patients with complex elbow dislocations have been pub-
lished [2,3,5-12]. These studies showed promising func-
tional results following treatment with a hinged elbow
fixator [11,12].
The primary objective of this prospective cohort study
is to study the functional outcome, pain, and health-
related quality of life in patients who sustained a com-
plex elbow dislocation and were treated with ORIF and/
or arthroplasty of the radial head and a hinged external
fixator due to residual instability. Our hypothesis is that
early mobilization will prevent stiffness and will result in
a satisfactory functional outcome at one year.
Methods/Design
Study design
Multi-center cohort study in all consecutive patients
who sustained a complex elbow dislocation and were
treated with a hinged external fixator for residual
instability after ORIF and/or arthroplasty of the radial
head. Sixteen centers in the Netherlands will participate.
The study started August 28, 2009.
Recruitment and consent
The decision to apply the hinged fixator for residual
instability following fracture fixation will be left to the
discretion of the surgeon. If a fixator is applied, patients
will receive information and a consent form from the
attending physician, the clinical investigator or a
research assistant postoperatively. Patients meeting all
inclusion criteria and none of the exclusion criteria will
be included before discharge or at the time of their first
outpatient visit (two weeks after surgery), which will
give them on average one week to consider their
participation.
Study population
Patients meeting the following inclusion criteria are eli-
gible for enrolment:
1. Men or women aged 18 years and older (with no
upper age limit)
2. Patient with a complex elbow dislocation (i.e., dislo-
cation of the elbow joint, combined with at least a frac-
ture of the radial head, coronoid process, or olecranon)
3. Patient was treated with a hinged external fixator
after ORIF and/or arthroplasty of the radial head due to
persistent instability
4. Provision of informed consent by patient
S i n c et h e r ei sc u r r e n t l yn oc o n s e n s u sr e g a r d i n gt h e
most valid and reliable test for assessing elbow joint
instability, this will be left to the discretion of the sur-
geon performing the operation. This reflects common
practice, and will increase translatability of the outcome
of our study. In order to warrant performance of stabi-
lity tests across participating sites, a detailed description
of stability tests (i.e., varus stability, valgus stability, and
pivot shift test for posterolateral rotatory stability) is
included in the protocol.
If any of the following criteria applies, patients will be
excluded:
1. Patients with a concomitant distal humeral fracture
2. Patients with additional substantial traumatic inju-
ries of the affected upper limb
3. Patients who underwent repair of the collateral
ligaments
4. Patients with an impaired elbow function (i.e., stiff
or painful elbow or neurological disorder of the upper
limb) prior to the injury
5. Retained hardware around the affected elbow
6. Likely problems, in the judgment of the investiga-
tors, with maintaining follow-up (e.g., patients with no
fixed address will be excluded)
7. Insufficient comprehension of the Dutch language
to understand the rehabilitation program and other
treatment information in the judgment of the attending
physician
Exclusion of a patient because of enrolment in another
ongoing drug or surgical intervention trial will be left to
the discretion of the attending surgeon on a case-by-
case basis.
Intervention
The external fixator used is the Orthofix
® Elbow Fixator
(Orthofix Verona, Italy). The surgical approach to the
fracture site is left to the surgeon’s discretion. Following
ORIF of the fractures and/or arthroplasty of the radial
head, the center of rotation of the elbow is identified.
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the capitellum humeri which is identified on an exact
lateral fluoroscopic image. Next, the external fixator is
mounted, first fixating the proximal humeral clamp and
subsequently the distal ulnar clamp. Exact reduction of
the elbow joint is evaluated with image intensifier in lat-
eral and anteroposterior direction during flexion and
extension. The surgical technique is described in more
details elsewhere [13]. After surgery, patients are
allowed to use a sling for two days to one week. Pin-site
care will be performed daily by the patient following
instruction given by the treating physician. After surgery
patients will receive indomethacin 2dd 50 mg for six
weeks (in combination with acid blocking medication)
in order to prevent heterotopic ossification of the elbow,
unless NSAIDs are contraindicated [14]. The external
fixator will be removed six weeks after surgery. Exten-
sion, flexion and pro- and supination active and passive
exercises are started immediately after surgery if toler-
ated under supervision of a professional physical thera-
pist, who they can freely select.
Outcome measures
The primary outcome measure is the Quick-DASH (Dis-
abilities of the Arm, Shoulder and Hand) score, which
reflects both function and pain after one year [15]. The
DASH Outcome Measure is a validated 30-item, self-
reported questionnaire designed to help describe the
disability experienced by people with upper-limb disor-
d e r sa n da l s ot om o n i t o rc h a n g e si ns y m p t o m sa n d
function over time [15,16].
The Quick-DASH is a shortened version of the DASH
Outcome Measure. Instead of 30 items, the Quick-
DASH uses 11 items (scored 1-5) to measure physical
function and symptoms in people with any or multiple
musculoskeletal disorders of the upper limb. The right
and left elbow will be assessed separately. At least 10 of
the 11 items must be completed for a score to be calcu-
lated. The scores will be transformed to a 0-100 scale
for easy comparison. A higher score indicates greater
disability. The test-retest reliability of the Quick-DASH
was 0.90 [17].
Like the DASH, the Quick-DASH also has two
optional modules intended to measure symptoms and
function in athletes, performing artists and other work-
ers whose jobs require a high degree of physical perfor-
mance. These optional models are scored separately;
each contains four items, scored 1-5. All items must be
completed for a score to be calculated.
The secondary outcome measures are:
￿ Functional outcome (Mayo Elbow Performance
Index and Oxford Elbow Score)
￿ Pain level at both sides (VAS)
￿ Range of Motion of the elbow joint at both sides
￿ Radiographic healing of the fractures
￿ Rate of secondary interventions
￿ Rate of complications
￿ Health-related quality of life (SF-36)
The Mayo Elbow Performance Index (MEPI) is one of
the most commonly used physician-based elbow rating
systems. This index consists of five parts: pain (with a
maximum score of 45 points), ulnohumeral motion (20
points), stability (ten points), the ability to perform five
functional tasks (5 × 5 points) and the patient response.
If the total score is between 90 and 100 points, it is con-
sidered excellent; between 75 and 89 points, good;
between 60 and 74 points, fair; and less than 60 points,
poor [18].
The Oxford Elbow Score is a 12-item questionnaire. It
is comprised of three one-dimensional domains: elbow
function, pain and social-psychological, with each
domain comprising of four items with good measure-
ment properties [19]. This is a validated questionnaire
in the UK and was translated to Dutch by the proper
translation procedure, which uses the technique of
translation and back-translation [20-22]. Permission for
translation and the use of the Oxford Elbow Score for
this study was obtained from Oxford and Isis Outcomes,
part of Isis Innovation Limited (website: http://www.isis-
innovation.com/)
Pain level will be determined using a 10-point Visual
Analog Scale (VAS), in which zero implies no pain and
ten implies the worst possible pain.
Range of motion (ROM) will be determined by mea-
sure flexion/extension and pro-/supination on both
sides using a goniometer.
Radiographic healing will be determined using X-rays.
Fractures are considered healed if one of the following
three criteria is met: (a) Bridging of fracture by callus/
bone trabeculae or osseous bone; (b) Obliteration of
fracture line/cortical continuity; (c) Bridging of fracture
at three cortices.
Secondary intervention within one year of initial treat-
ment to promote fracture healing, relieve pain, treat
infection, or improve function will be recorded. This
includes incision and drainage for surgical site infection
or deep infection, repositioning or removal of the fixa-
tor, reosteosynthesis, implant removal, or ligament
repair.
Complications within one year of initial treatment will
be recorded. These include heterotopic ossification,
infections, bleeding, venous thrombosis, and neurologi-
cal deficits)
The Short-Form 36 (SF-36) is a validated multi-pur-
pose, short-form health survey with 36 questions that
represent eight health domains that are combined into a
physical and a mental component scale [23]. The Physical
Component Scale (PCS) combines the health domains of
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to physical health (RP; four items), bodily pain (BP; two
items), and general health perceptions (GH; five items).
The Mental Component Scale (MCS) combines the
health domains of vitality, energy, or fatigue (VT; four
items), social functioning (SF; two items), role limitations
due to emotional problems (RE; three items), and general
mental health (MH; five items). Scores ranging from zero
to 100 points are derived for each domain, with lower
scores indicating poorer function. These scores will be
converted to a norm-based score and compared with the
norms for the general population of the United States
(1998), in which each scale was scored to have the same
average (50 points) and the same standard deviation (ten
points).
In addition to the outcome variables mentioned above,
the following data will be collected:
1. Intrinsic variables (baseline data): age, gender,
American Society of Anesthesiologists’ ASA classifica-
tion, tobacco consumption, alcohol consumption,
comorbidity, dominant side, medication use, Quick-
DASH score prior to the injury, pain level at both sides
prior to the injury (VAS), and SF-36 score prior to the
injury.
2. Injury related variables: affected side, mechanism of
injury, and postoperative assessment of varus, valgus
and posterolateral rotatory instability, fracture location
(i.e., radial head, coronoid process, olecranon), fracture
classification of the coronoid process according to
Regan & Morrey [24], and fracture classification of the
radial head according to Mason & Johnston [25].
3. Intervention-related variables: surgical delay (i.e.,
time between fracture and surgery), time between injury
and start of physical therapy, and number of physical
therapy sessions
Study procedures [Table 1]
Clinical assessments will take place at the time of
admission to the hospital (baseline), two weeks (7-28
days window), six weeks (4-8 weeks window), three
months (11-15 weeks window), six months (5-7 months
window), and 12 months (12-14 months window) after
surgery. At each follow-up moment, the research coor-
dinator or research assistant will ascertain patient status
(i.e., secondary interventions, adverse events/complica-
tions), and will verify information within medical
records. At the last visit, the surgeon will document any
surgery that may be planned for the patient.
Anteroposterior and lateral X-rays of the elbow will be
made at the time of presentation to the hospital (base-
line), within 48 hours post surgery, and at all follow-up
visits listed above. These X-rays will be used to deter-
mine the time to radiographic healing and amount and
location of heterotopic ossification.
At baseline, patients will be asked to complete the
Quick-D A S H ,V A S ,a n dS F - 3 6q u e s t i o n n a i r e s .T h i s
relates to the situation prior to the injury, so in order to
minimize recall bias as much as possible, the question-
naires will be completed as soon after surgery as possi-
ble. At the two weeks follow-up visit and each visit
thereafter, the range of motion of the elbow joint will be
measured by a doctor or research assistant using a goni-
ometer. At these follow-up visits, the patients will com-
plete a questionnaire relating to pain (VAS). The MEPI
index will be determined from six weeks onwards. At
the six week follow-up visit and each visit thereafter
patients will be asked to complete the Quick-DASH,
Oxford Elbow Score, and SF-36 questionnaires.
Sample size calculation
Calculation of the required sample size for this study is
not constructive. This study is a case series based on
the assumption that for introducing and acquiring
experience in a new operative technique a sample size
of 30 patients is required [26,27].
Statistical analysis
Data will be analyzed using the PASW Statistics version
18.0.1 or higher (SPSS, Chicago, Illinois, USA). Normal-
ity of continuous data will be checked by inspecting the
frequency distributions (histograms) and normal Q-Q
plots. Data will be reported in compliance with the
CONSORT (CONsolidation of Standards of Reporting
Trials) guidelines [28,29]. In the unlikely event that a
fixator will be removed within six weeks, patients will
be followed and analyzed on an intention to treat basis.
Descriptive analysis will be performed in order to
report baseline characteristics (i.e., intrinsic, injury-
related and fracture-related variables) and outcome mea-
sures. For continuous variables (e.g., age, Quick-DASH
s c o r e ,M E P I ,V A S ,a n dS F - 3 6s c o r e )m e a n±S D( i fn o r -
mally distributed) or medians and percentiles (if not nor-
mally distributed) will be calculated. For categorical
variables (e.g., gender, ASA grade, alcohol and tobacco
consumption, dominant and affected side) frequencies
will be calculated.
Multiple linear regression analysis will be performed
in order to model the relation between different cov-
ariates and the Quick-DASH score. Intrinsic and frac-
ture-related variables will be added as covariate.
Similar models will be made to model the relation
between covariates and the other outcome measures. A
p-value < 0.05 will be taken as the threshold of statisti-
cal significance.
Ethical considerations
The study will be conducted according to the principles
of the Declaration of Helsinki (59th World Medical
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and in accordance with the Medical Research Involving
Human Subjects Act (WMO).
The Medical Ethics Committee Erasmus MC (Rotter-
dam, The Netherlands) acts as central ethics committee
for this trial (reference number MEC-2009-240;
NL28503.078.09). Approval has been obtained from the
local Medical Ethics Committees in all participating cen-
ters. Obtaining medical ethics approval has coordinated
and organized by a central research coordinator
(EMMVL), who is part of the key investigator team and
employed by the initiating site Erasmus MC. She pre-
pared all documents for the participating sites and
answered questions of the local ethics committees if
there were any. This was always following review and
approval of the site principal investigator. All participat-
ing surgeons have had GCP training previously or were
trained at the initiation visit in order to meet legal
requirements.
An information letter notifying the patients’ participa-
tion will be sent to their general practitioners, unless a
patient does not agree with this.
The Medical Ethics Committee Erasmus MC has given
dispensation from the statutory obligation to provide
insurance for subjects participating in medical research
(article 7, subsection 6 of the WMO and Medical
Research (Human Subjects) Compulsory Insurance
Decree of 23 June 2003). The reason for this dispensa-
tion is that participation in this study is without risks.
Discussion
The outcome of this study will yield quantitative data on
the functional outcome patients with a complex elbow
dislocation and who are treated with ORIF and addi-
tional stabilization with a hinged elbow fixator. Early
functional treatment may lead to a better ROM and pre-
vent elbow stiffness. Furthermore, the data as collected
during this study may be used for designing future (ran-
domized) clinical trials. Inclusion of patients has been
started August 28, 2009 and the expectation is to
include 2-3 patients per month. With a follow-up of one
year the presentation of data will be expected at the end
of 2012.
Specified notice
Oxford Elbow Score
© Isis Innovation Limited, 2008. All
rights reserved. The authors, being Professor Ray Fitzpa-
trick and Dr Jill Dawson, have asserted their moral
rights.
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Table 1 Schedule of events
Screening Enrolment Baseline < 48 h post-
surgery
2 weeks
(7-28 d)
6 weeks
(4-8 we)
3 months
(11-15 we)
6 months
(5-7 mo)
12 months
(12-14 mo)
Screening X
X-ray X X X X X X X
Informed
Consent
X
Baseline data X
Quick-DASH X X X X X
Pain (VAS) X X X X X X
SF-36 X X X X X
Clinical
follow-up
XX X X X
Revision
surgery
XX X X X
Complications X X X X X
ROM X X X X X
MEPI X X X X
Oxford Elbow
Score
XX X X
Early
withdrawal
** ** * *
*, only if applicable.
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